Ventracor’s heart gives out
19 March, 2009 by Kate McDonaldVentracor in voluntary administration after failing to secure funds
Rabies infection from dog meat
19 March, 2009 by Kate McDonaldTwo cases of rabies infection from eating dog and cat meat reported
Australian biotech market today 18.03.09
18 March, 2009 by Kate McDonaldAlchemia, Avexa, Cytopia, Genera Biosystems, Universal Biosensors
Australian biotech market today 17.03.09
17 March, 2009 by Kate McDonaldAvexa, Cochlear, Acrux, Peplin, Clinuvel, pSivida
Positive results for Avexa
16 March, 2009 by Staff WritersAvexa reports impressive results for apricitabine in HIV+ patients
Australian biotech market today 16.03.09
16 March, 2009 by Kate McDonaldCochlear, CSL, Resmed, Sonic Healthcare, Avexa, Novogen, Alchemia, Biotron
Generic opportunity for Alchemia
13 March, 2009 by Kate McDonaldAlchemia’s partner files generic application for fondaparinux
pSivida eyes Iluvian
13 March, 2009 by Kate McDonaldGood early results for pSivida’s intra-vitreal insert
Australian biotech market today 13.03.09
13 March, 2009 by Kate McDonaldAlchemia, pSivida, CSL, Acrux, Cellestis
NuSep erects NxGen prospectus
12 March, 2009 by Kate McDonaldNuSep plans to raise cash for NxGen acquisition
Italy and Japan for Fermiscan
12 March, 2009 by Kate McDonaldHitachi Chemical takes option on Fermiscan licence, Italy look promising
Progen-Avexa deal goes bung
10 March, 2009 by Kate McDonaldProgen forced to drop Avexa merger after overwhelming no vote
Update: Big Pharma mega-merger dramarama
10 March, 2009 by Kate McDonaldMerck and Schering-Plough; Pfizer and Wyeth; Roche and Genentech
Polartechnics moves into Pakistan
09 March, 2009 by Kate McDonaldPakistan government orders cervical cancer screen
Arana completes Phase II
09 March, 2009 by Kate McDonaldAntibody company Arana completes Phase II trial of anti-TNF drug for psoriasis
